Oxytocin and vasopressin V1A receptors as new therapeutic targets in assisted reproduction

Reproductive BioMedicine Online

Volumn 22, Issue 1, 2011, Pages 9-16

  Pierzynski, Piotr ^a  

^a Centre for Reproductive Medicine London (CRM London)   (United Kingdom)

Author keywords

Embryo implantation; Embryo transfer; Oxytocin antagonist; Vasopressin V 1A antagonist

Indexed keywords

ATOSIBAN; BARUSIBAN; CALCIUM CHANNEL; GSK 221149 A; N [ 2 HYDROXY 2 PHENYLETHYL] 4 (METHOXYIMINO) 1 [(2 METHYL[1,1' BIPHENYL]- -YL)CARBONYL] 2 PYRROLIDINECARBOXAMIDE; NIFEDIPINE; OXYTOCIN; OXYTOCIN ANTAGONIST; PLACEBO; PROSTAGLANDIN; RELCOVAPTAN; SSR 126768 A; UNCLASSIFIED DRUG; UTERUS SPASMOLYTIC AGENT; VASOPRESSIN V1A RECEPTOR;

CLINICAL TRIAL; DRUG TARGETING; DYSMENORRHEA; EGG PRODUCTION; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HUMAN; NONHUMAN; PREGNANCY; PREGNANCY RATE; PREMATURITY; REPRODUCTION; REVIEW; UTERUS CONTRACTION;

ANIMALS; EMBRYO IMPLANTATION; FEMALE; HUMANS; INDOLES; INFERTILITY; OLIGOPEPTIDES; OXYTOCIN; PREGNANCY; PYRROLIDINES; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; REPRODUCTIVE TECHNIQUES, ASSISTED; TOCOLYTIC AGENTS; UTERINE CONTRACTION; VASOPRESSINS; VASOTOCIN;

EID: 78650511425     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2010.09.015     Document Type: Review

References (86)

1. M. Akerlund Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhea Prog. Brain Res. 139 2002 359 365
2. M. Akerlund, T. Bossmar, and R. Brouard Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women Br. J. Obstet. Gynaecol. 106 1999 1047 1053
3. J. Amico, S. Seif, and A. Robinson Elevation of oxytocin and the oxytocin-associated neurophysin in the plasma of normal women during midcycle J. Clin. Endocrinol. Metab. 53 1981 1229 1232
4. J.M. Ayoubi, M. Epiney, P.A. Brioschi, R. Fanchin, D. Chardonnens, and D. De Ziegler Comparison of changes in uterine contraction frequency after ovulation in the menstrual cycle and in in vitro fertilization cycles Fertil. Steril. 79 2003 1101 1105
5. R. Bernabeu, M. Roca, A. Torres, and J. Ten Indomethacin effect on implantation rates in oocyte recipients Hum. Reprod. 21 2006 364 369
6. B. Bishara, H. Shiekh, and T. Karram Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure J. Pharmacol. Exp. Ther. 326 2008 414 422
7. Blockeel, C., Pierson, R., Popovic-Todorovic, B., et al., 2009. Effects of barusiban and atosiban on frequency of uterine contractions in the luteal phase after stimulation: a randomised placebo controlled trial. Hum. Reprod. 24 (Suppl. 1), i26.
8. T. Bossmar, N. Osman, E. Zilahi, M.A. Haj, N. Nowotny, and J.M. Conlon Expression of the oxytocin gene, but not the vasopressin gene, in the rat uterus during pregnancy: influence of oestradiol and progesterone J. Endocrinol. 193 2007 121 126
9. T. Bossmar, M. Akerlund, J. Szamatowicz, T. Laudanski, G. Fantoni, and M. Maggi Receptor-mediated uterine effects of vasopressin and oxytocin in nonpregnant women Br. J. Obstet. Gynaecol. 102 1995 907 912
10. G.T. Braileanu, S.M. Simasko, J. Hu, A. Assiri, and M.A. Mirando Effects of arginine- and lysine-vasopressin on phospholipase c activity, intracellular calcium concentration and prostaglandin F2alpha secretion in pig endometrial cells Reproduction 121 2001 605 612
11. C. Bulletti, D. De Ziegler, P.L. Setti, E. Cicinelli, V. Polli, and C. Flamigni The patterns of uterine contractility in normal menstruating women: from physiology to pathology Ann. N. Y. Acad. Sci. 1034 2004 64 83
12. P. Cassoni, T. Marrocco, and B. Bussolati Oxytocin induces proliferation and migration in immortalized human dermal microvascular endothelial cells and human breast tumor-derived endothelial cells Mol. Cancer Res. 4 2006 351 359
13. M. Cavagna, and J.C. Mantese Biomarkers of endometrial receptivity-a review Placenta 24 Suppl. B 2003 S39 S47
14. R. Chibbar, F.D. Miller, and B.F. Mitchell Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition J. Clin. Invest. 91 1993 185 192
15. R. Chibbar, S. Wong, F.D. Miller, and B.F. Mitchell Estrogen stimulates oxytocin gene expression in human chorio-decidua J. Clin. Endocrinol. Metab. 80 1995 567 572
16. R. Cirillo, E. Gillio Tos, and M.K. Schwarz Pharmacology of (2s, 4z)-n-[(2s)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2′-methyl[1, 1′-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor J. Pharmacol. Exp. Ther. 306 2003 253 261
17. De Heus, R., Mulder, E.J., Derks, J.B., Visser, G.H., 2008. Acute tocolysis for uterine activity reduction in term labor: a review. Obstet. Gynecol. Surv. 63, 383-388; 405.
18. C. Dorn, J. Reinsberg, H. Schlebusch, G. Prietl, H. Van Der Ven, and D. Krebs Serum oxytocin concentration during embryo transfer procedure Eur. J. Obstet. Gynecol. Reprod. Biol. 87 1999 77 80
19. M. Duras, J. Mlynarczuk, and J. Kotwica Non-genomic effect of steroids on oxytocin-stimulated intracellular mobilization of calcium and on prostaglandin F2alpha and E2 secretion from bovine endometrial cells Prostaglandins Other Lipid Mediat. 76 2005 105 116
20. European Atosiban Study Group The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study Acta Obstet. Gynecol. Scand. 80 2001 413 422
21. European Medicines Agency, 2009. Tractocile (atosiban)-european public assessment report revision 12. In: European Medicines Agency. Available from: .
22. R. Fanchin Uterine dynamics: impact on the human reproduction process Reprod. Biomed. Online 18 Suppl. 2 2009 57 62
23. R. Fanchin, C. Righini, F. Olivennes, S. Taylor, D. De Ziegler, and R. Frydman Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization Hum. Reprod. 13 1998 1968 1974
24. R. Fanchin, J.M. Ayoubi, C. Righini, F. Olivennes, L.M. Schonauer, and R. Frydman Uterine contractility decreases at the time of blastocyst transfers Hum. Reprod. 16 2001 1115 1119
25. A.P. Flint, W.M. Leat, E.L. Sheldrick, and H.J. Stewart Stimulation of phosphoinositide hydrolysis by oxytocin and the mechanism by which oxytocin controls prostaglandin synthesis in the ovine endometrium Biochem. J. 237 1986 797 805
26. G. Gimpl, and F. Fahrenholz The oxytocin receptor system: Structure, function, and regulation Physiol. Rev. 81 2001 629 683
27. D.A. Giussani, S.L. Jenkins, and C.A. Mecenas The oxytocin antagonist atosiban prevents androstenedione-induced myometrial contractions in the chronically instrumented, pregnant rhesus monkey Endocrinology 137 1996 3302 3307
28. T.M. Goodwin The gordian knot of developing tocolytics J. Soc. Gynecol. Invest. 11 2004 339 341
29. T.M. Goodwin, L. Millar, L. North, L.S. Abrams, R.C. Weglein, and M.L. Holland The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions Am. J. Obstet. Gynecol. 173 1995 913 917
30. T.M. Goodwin, G.J. Valenzuela, H. Silver, and G. Creasy Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban study group Obstet. Gynecol. 88 1996 331 336
31. T. Kimura, M. Takemura, and S. Nomura Expression of oxytocin receptor in human pregnant myometrium Endocrinology 137 1996 780 785 (Pubitemid 26043774)
32. G. Kunz, and G. Leyendecker Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction Reprod. Biomed. Online 4 Suppl. 3 2002 5 9
33. G. Kunz, D. Beil, H. Deiniger, A. Einspanier, G. Mall, and G. Leyendecker The uterine peristaltic pump. Normal and impeded sperm transport within the female genital tract Adv. Exp. Med. Biol. 424 1997 267 277
34. D. Lefebvre, A. Giaid, H. Bennet, R. Larvriere, and H. Zingg Oxytocin gene expression in rat uterus Science 256 1992 1553 1555
35. J.W. Lemaster, R.C. Seals, F.M. Hopkins, and F.N. Schrick Effects of administration of oxytocin on embryonic survival in progestogen supplemented cattle Prostaglandins Other Lipid Mediat. 57 1999 259 268
36. P. Lesny, S.R. Killick, J. Robinson, G. Raven, and S.D. Maguiness Junctional zone contractions and embryo transfer: is it safe to use a tenaculum? Hum. Reprod. 14 1999 2367 2370
37. P. Lesny, S.R. Killick, R.L. Tetlow, D.J. Manton, J. Robinson, and S.D. Maguiness Ultrasound evaluation of the uterine zonal anatomy during in-vitro fertilization and embryo transfer Hum. Reprod. 14 1999 1593 1598
38. Y.L. Liang, T.C. Kuo, K.H. Hung, T.H. Chen, and M.H. Wu Oxytocin antagonist for repeated implantation failure and delay of delivery Taiwan J. Obstet. Gynecol. 48 2009 314 316
39. Z. Liang, S.R. Sooranna, and N. Engineer Prostaglandin F2-alpha receptor regulation in human uterine myocytes Mol. Hum. Reprod. 14 2008 215 223
40. J. Liddle, M.J. Allen, and A.D. Borthwick The discovery of gsk221149a: a potent and selective oxytocin antagonist Bioorg. Med. Chem. Lett. 18 2008 90 94
41. R. Liedman, S.R. Hansson, and D. Howe Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects Gynecol. Endocrinol. 24 2008 508 513
42. T. Ludwig, S. Whiteaker, K. Carnahan, K. Tysseling, and M. Mirando Control of endometrial phosphoinositide hydrolysis and prostaglandin f2a secretion in pigs Reprod. Fertil. Dev. 10 1998 249 254
43. L.W. Mackenzie, R.A. Word, M.L. Casey, and J.T. Stull Myosin light chain phosphorylation in human myometrial smooth muscle cells Am. J. Physiol. 258 1990 C92 C98
44. M. Maggi, G. Fantoni, and A. Peri Steroid modulation of oxytocin/vasopressin receptors in the uterus J. Steroid Biochem. Mol. Biol. 40 1991 481 491
45. M. Maggi, A. Magini, and A. Fiscella Sex steroid modulation of neurohypophysial hormone receptors in human nonpregnant myometrium J. Clin. Endocrinol. Metab. 74 1992 385 392
46. R.T. Mansour, M.A. Aboulghar, G.I. Serour, and Y.M. Amin Dummy embryo transfer using methylene blue dye Hum. Reprod. 9 1994 1257 1259
47. C.A. Mecenas, D.A. Giussani, and J.R. Owiny Production of premature delivery in pregnant rhesus monkeys by androstenedione infusion Nat. Med. 2 1996 443 448
48. Y. Menezo, D. Anker, and J. Salat-Baroux Conception and realization of artificial dyed embryos for training in in vitro fertilization and embryo transfer (IVF and ET) Acta Eur. Fertil. 16 1985 55 58
49. M. Molnar, J. Rigo Jr., R. Romero, and F. Hertelendy Oxytocin activates mitogen-activated protein kinase and up-regulates cyclooxygenase-2 and prostaglandin production in human myometrial cells Am. J. Obstet. Gynecol. 181 1999 42 49
50. H.S. Moon, S.H. Park, J.O. Lee, K.S. Kim, and B.S. Joo Treatment with piroxicam before embryo transfer increases the pregnancy rate after in vitro fertilization and embryo transfer Fertil. Steril. 82 2004 816 820
51. O. Moraloglu, E. Tonguc, T. Var, T. Zeyrek, and S. Batioglu Treatment with oxytocin antagonists before embryo transfer may increase implantation rates after ivf Reprod. Biomed. Online 21 2010 338 343
52. A. Nohara, M. Ohmichi, and K. Koike The role of mitogen-activated protein kinase in oxytocin-induced contraction of uterine smooth muscle in pregnant rat Biochem. Biophys. Res. Commun. 229 1996 938 944
53. A. Nyboe-Andersen, V. Goossens, and S. Bhattacharya Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF monitoring programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE) Hum. Reprod. 24 2009 1267 1287
54. M. Ohmichi, K. Koike, and A. Nohara Oxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells Endocrinology 136 1995 2082 2087
55. C.A. Pedersen, and M.L. Boccia Vasopressin interactions with oxytocin in the control of female sexual behavior Neuroscience 139 2006 843 851
56. R. Pierson, J.J. Deptuch, J. Invik, B.M. Klein, V. Breinholt, and J.C. Arce Reproducibility of uterine contractility assessments based on transvaginal ultrasound cine-loop recordings Hum. Reprod. 24 Suppl. 1 2009 i103
57. P. Pierzynski, A. Lemancewicz, T. Reinheimer, M. Akerlund, and T. Laudanski Inhibitory effect of barusiban and atosiban on oxytocin-induced contractions of myometrium from preterm and term pregnant women J. Soc. Gynecol. Invest. 11 2004 384 387
58. P. Pierzynski, B. Gajda, Z. Smorag, A.D. Rasmussen, and W. Kuczynski Effect of atosiban on rabbit embryo development and human sperm motility Fertil. Steril. 87 2007 1147 1152
59. P. Pierzynski, T.M. Reinheimer, and W. Kuczynski Oxytocin antagonists may improve infertility treatment Fertil. Steril. 88 2007 e19 e22
60. A.N. Poindexter 3rd, D.J. Thompson, W.E. Gibbons, W.E. Findley, M.G. Dodson, and R.L. Young Residual embryos in failed embryo transfer Fertil. Steril. 46 1986 262 267
61. T.M. Reinheimer, G.J. Chellman, J.C. Resendez, J.K. Meyer, and W.H. Bee Barusiban, an effective long-term treatment of oxytocin-induced preterm labor in nonhuman primates Biol. Reprod. 75 2006 809 814
62. T.M. Reinheimer, W.H. Bee, J.C. Resendez, J.K. Meyer, G.J. Haluska, and G.J. Chellman Barusiban, a new highly potent and long-acting oxytocin antagonist: Pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor J. Clin. Endocrinol. Metab. 90 2005 2275 2281
63. O.N. Richter, K. Kubler, and J. Schmolling Oxytocin receptor gene expression of estrogen-stimulated human myometrium in extracorporeally perfused non-pregnant uteri Mol. Hum. Reprod. 10 2004 339 346
64. A. Salonia, R.E. Nappi, and M. Pontillo Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women Horm. Behav. 47 2005 164 169
65. B. Sanborn, B. Dodge, M. Monga, A. Qian, W. Wang, and C. Yue Molecular mechanisms regulating the effects of oxytocin on myometrial intracellular calcium Adv. Exp. Med. Biol. 449 1998 277 286
66. R.C. Seals, J.W. Lemaster, F.M. Hopkins, and F.N. Schrick Effects of elevated concentrations of prostaglandin F2 alpha on pregnancy rates in progestogen supplemented cattle Prostaglandins Other Lipid Mediat. 56 1998 377 389
67. C. Serradeil-Le Gal, G. Valette, and L. Foulon Ssr126768a (4-chloro-3-[(3r)-(+)-5-chloro-1-(2, 4-dimethoxybenzyl)-3-methyl-2-oxo-2, 3- dihydro-1h-indol-3-yl]-n-ethyl-n-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor J. Pharmacol. Exp. Ther. 309 2004 414 424
68. L. Shukovski, D. Healy, and J. Findlay Circulating immunoreactive oxytocin during the human menstrual cycle comes from the pituitary and is estradiol dependent J. Clin. Endocrinol. Metab. 68 1989 455 460
69. W. Silvia, D. Trammell, S. Hayes, L. Lowberger, and J. Brockman Cellular mechanisms mediating the stimulation of ovine endometrial secretion of prostaglandin F2 in response to oxytocin: role of phospholipase c and diacyloglicerol J. Endocrinol. 141 1994 481 490 (Pubitemid 24218848)
70. S.K. Smith, and R.W. Kelly The release of PGF2 alpha and PGE2 from separated cells of human endometrium and decidua Prostaglandins Leukot. Essent. Fatty Acids 33 1988 91 96
71. M. Steinwall, T. Bossmar, C. Gaud, and M. Akerlund Inhibitory effects of SR 49059 on oxytocin-and vasopressin-induced uterine contractions in non-pregnant women Acta Obstet. Gynecol. Scand. 83 2004 12 18
72. M. Steinwall, S. Hansson, T. Bossmar, I. Larsson, R. Pilka, and M. Akerlund Oxytocin mRNA content in the endometrium of non-pregnant women BJOG 111 2004 266 270
73. M. Steinwall, T. Bossmar, and R. Brouard The effect of relcovaptan (SR 49059), an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labor Gynecol. Endocrinol. 20 2005 104 109
74. F. Stormshak Biochemical and endocrine aspects of oxytocin production by the mammalian corpus luteum Reprod. Biol. Endocrinol. 1 2003 92
75. M. Thibonnier, C. Auzan, Z. Madhun, P. Wilkins, L. Berti-Mattera, and E. Clauser Molecular cloning, sequencing, and functional expression of a cdna encoding the human V1a vasopressin receptor J. Biol. Chem. 269 1994 3304 3310
76. S. Thornton, T.M. Goodwin, G. Greisen, M. Hedegaard, and J.C. Arce The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial Am. J. Obstet. Gynecol. 200 2009 e1 e10
77. C. Tomas, K. Tikkinen, L. Tuomivaara, J.S. Tapanainen, and H. Martikainen The degree of difficulty of embryo transfer is an independent factor for predicting pregnancy Hum. Reprod. 17 2002 2632 2635
78. Tsirigotis, M., Pelekanos, M., Gilhespie, S., Gregorakis, S., Pistofidis, G., 2000. Ritodrine use during the peri-implantation period reduces uterine contractility and improves implantation and pregnancy rates post-ivf. Hum. Reprod. 15, (Abs. Bk 1), O-024, 10.
79. J. Tsukada, A. Tahara, and Y. Tomura Pharmacologic properties of YM218, a novel, potent, nonpeptide vasopressin V1a receptor-selective antagonist Vascul. Pharmacol. 42 2005 47 55
80. M. Uzumcu, K.G. Carnahan, G.T. Braileanu, and M.A. Mirando Oxytocin-stimulated phosphoinositide hydrolysis and prostaglandin F2alpha secretion by luminal epithelial, glandular epithelial and stromal cells from pig endometrium. Ii. Responses of cyclic, pregnant and pseudopregnant pigs on days 12 and 16 post oestrus Reprod. Fertil. Dev. 12 2000 157 164
81. Uzumcu, M., Braileanu, G., Carnahan, K., Ludwig, T., Mirando, M., 1998. Oxytocin-stimulated phosphoinositide hydrolysis and prostaglandin F2a secretion by luminal epithelial, glandular epithelial and stromal cells from pig endometrium. I. Response of cyclic pigs on day 16 post-estrus. Biol. Reprod. 59, 1256-1265.
82. Vedernikov, Y., Betancourt, A., Shi, S., Shi, L., Reinheimer, T., Garfield, R., 2006 Oxytocin antagonistic effect of barusiban and atosiban in isolated uterine artery from late pregnant rats. In: Annual scientific meeting of the Society for Gynecologic Investigation. Toronto, Canada.
83. Visnova, H., Coroleu, B., Piro, M., Blockeel, C., Mrazek, M., Arce, J.C., 2009. Barusiban and atosiban for reduction of uterine contractions on day of embryo transfer do not alter the endocrine profile at time of implantation. Hum. Reprod. 24 (Suppl. 1), i178.
84. S. Whiteaker, M. Mirando, W. Becker, and C. Hostetler Detection of functional oxytocin receptors on endometrium of pigs Biol. Reprod. 51 1994 91 98
85. D.A. Wing, N. Goharkhay, J.C. Felix, M. Rostamkhani, Y.M. Naidu, and B.W. Kovacs Expression of the oxytocin and V1a vasopressin receptors in human myometrium in differing physiologic states and following misoprostol administration Gynecol. Obstet. Invest. 62 2006 181 185
86. H. Zingg Oxytocin L. De Groot, J. Jameson, Endocrinology 2000 W B Saunders